A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer

MLA

Sophie Mouillet-Richard, et al. “A Proof of Concept for Targeting the PrPC - Amyloid β Peptide Interaction in Basal Prostate Cancer and Mesenchymal Colon Cancer.” Oncogene, vol. 41, Aug. 2022, pp. 4397–404. EBSCOhost, https://doi.org/10.1038/s41388-022-02430-7.

APA

Sophie Mouillet-Richard, Séverine Martin-Lannerée, Delphine Le Corre, Théo Z. Hirsch, Alexandre Ghazi, Marine Sroussi, Camilla Pilati, Aurélien de Reyniès, Fatima Djouadi, Nicolas Vodovar, Jean-Marie Launay, & Pierre Laurent-Puig. (2022). A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer. Oncogene, 41, 4397–4404. https://doi.org/10.1038/s41388-022-02430-7

Chicago

Sophie Mouillet-Richard, Séverine Martin-Lannerée, Delphine Le Corre, Théo Z. Hirsch, Alexandre Ghazi, Marine Sroussi, Camilla Pilati, et al. 2022. “A Proof of Concept for Targeting the PrPC - Amyloid β Peptide Interaction in Basal Prostate Cancer and Mesenchymal Colon Cancer.” Oncogene 41 (August): 4397–4404. doi:10.1038/s41388-022-02430-7.